v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Class A ordinary shares
At-the-Market Offering
Class A ordinary shares
Class A preference shares
Class A II preference shares
Class B ordinary shares
Ordinary shares
At-the-Market Offering
Ordinary shares
Preference shares
Additional paid-in capital
At-the-Market Offering
Additional paid-in capital
Treasury shares
Accumulated other comprehensive loss
Accumulated deficit and statutory reserve
Cumulative-effect
Accumulated deficit and statutory reserve
Non-controlling interests
At-the-Market Offering
Cumulative-effect
Total
Balance at Dec. 31, 2022             $ 54 $ 0   $ 620,807 $ (21,604) $ (3,960)   $ (542,169) $ 0     $ 53,128
Balance, shares at Dec. 31, 2022   1,063,813,210 65,000 0 99                          
Net loss                           (28,710)       (28,710)
Foreign currency translation loss                       (316)           (316)
Share-based compensation                   1,030               $ 1,030
Share-based compensation, shares   47,419,000                               47,419,000
Balance at Dec. 31, 2023             54     621,837 (21,604) (4,276)   (570,879)       $ 25,132
Balance, shares at Dec. 31, 2023   1,111,232,210 65,000   99                          
Accounting Standards Update [Extensible Enumeration]                                 Accounting Standards Update 2023-08 [Member]  
Net loss                           12,073 (154)     11,919
Foreign currency translation loss                       (116)           (116)
Share-based compensation             2     1,143               $ 1,145
Share-based compensation, shares   40,318,000                               40,318,000
Issuance of ordinary shares for asset acquisition             18     15,311               $ 15,329
Issuance of ordinary shares for asset acquisition, shares   369,031,800                                
Issuance of ordinary shares as incentive shares                   69               69
Issuance of ordinary shares as incentive shares, shares   2,291,280                                
Issuance of ordinary shares from exercise of Series B warrants                   30               30
Issuance of ordinary shares from exercise of Series B warrants, shares   500,000                                
Issuance of ordinary shares under At-The-Market offering           $ 4     $ 2,334             $ 2,338    
Issuance of ordinary shares under At-The-Market offering, shares 72,026,600 72,026,600                                
Non-controlling interests arising from acquisition of subsidiaries                             10,041     10,041
Balance at Dec. 31, 2024             78     640,724 (21,604) (4,392) $ 893 (557,913) 9,887   $ 893 66,780
Balance, shares at Dec. 31, 2024   1,595,399,890 65,000   99                          
Net loss                           (33,877) (603)     (34,480)
Foreign currency translation loss                       146           146
Share-based compensation             1     850               $ 851
Share-based compensation, shares   38,644,400                               38,644,400
Issuance of ordinary shares for asset acquisition             2     (2)                
Issuance of ordinary shares for asset acquisition, shares   45,278,600                                
Issuance of ordinary shares under At-The-Market offering           $ 9     $ 10,620 65           $ 10,629   $ 65
Issuance of ordinary shares under At-The-Market offering, shares 188,530,600 188,530,600   65,000                            
Reallocation of equity interest in subsidiary                   (475)         (8,788)     (9,263)
Balance at Dec. 31, 2025             $ 90     $ 651,782 $ (21,604) $ (4,246)   $ (591,790) $ 496     $ 34,728
Balance, shares at Dec. 31, 2025   1,867,853,490 65,000 65,000 99